Optical coherence tomography in multiple sclerosis: A 3-year prospective multicenter study
In this peer-reviewed long term, prospective study[1] of patients with intermittent multiple sclerosis published in the Annals of Clinical and Translational Neurology, SPECTRALIS OCT was used to image inner retinal layers with the authors noting, “OCT has potential to estimate rates of neurodegeneration in the retina and brain.”
[1]Paul, F., Calabresi, P.A., Barkhof, F., Green, A.J., Kardon, R., Sastre-Garriga, J., Schippling, S., Vermersch, P., Saidha, S., Gerendas, B.S., Schmidt-Erfurth, U., Agoropoulou, C., Zhang, Y., Seifer, G. and Petzold, A. (2021), Optical coherence tomography in multiple sclerosis: A 3-year prospective multicenter study. Ann Clin Transl Neurol. https://doi.org/10.1002/acn3.51473